Radiation kills cells. Higher doses kill more cells. This is the basis of radiotherapy — deliver enough dose to the tumor to kill it, and as little as possible to the surrounding tissue. The dose rate — how fast the radiation is delivered — has traditionally been considered secondary. A given dose should do a given amount of damage regardless of delivery speed.
The FLASH effect inverts this. At ultra-high dose rates, normal tissues are spared relative to tumors. The same total dose, delivered faster, causes less damage to healthy tissue while maintaining tumor control. The mechanism is not fully understood, but it may involve oxygen depletion — the ultra-fast delivery consumes local oxygen before it can mediate radiation chemistry, and the resulting hypoxia protects normal tissue.
Mayfield, Sherlock, and colleagues (arXiv:2602.20460) report the first in vivo study using laser-driven proton beams — uniquely short pulses with the highest instantaneous dose rates available. The results: less tissue swelling compared to conventional X-ray irradiation at the same total dose. RNA sequencing reveals differential gene expression in immune and epidermal programs — the tissue responds differently at the transcriptional level, not just at the damage level. The tissue doesn't just receive less damage; it processes the damage through different biological pathways.
The combination of protons (which deposit dose precisely at tumor depth) and FLASH delivery (which spares normal tissue at the delivery point) could double the therapeutic advantage. Precise spatial targeting and temporal protection stack multiplicatively.
The general observation: the effect of a perturbation depends not just on its total magnitude but on its delivery rate. Fast enough delivery can trigger qualitatively different responses — protective pathways that slower delivery does not activate. Speed is not just efficiency; it is a biological variable.